查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870841

牛健康管理市场按产品类型、通路、牛品种、疾病类型、给药途径和应用进行划分－2025年至2032年全球预测

Cattle Health Market by Product Type, Distribution Channel, Cattle Type, Disease Type, Route Of Administration, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，牛健康市场规模将达到 123.2 亿美元，复合年增长率为 5.76%。

关键市场统计数据
基准年 2024 78.7亿美元
预计年份：2025年 83.3亿美元
预测年份 2032 123.2亿美元
复合年增长率 (%) 5.76%

对重新定义现代畜牧管理中牛健康优先事项、临床实践和农场层面决策的因素进行了简要的背景概述。

牛健康管理领域正处于一个十字路口，科学进步、法规演变和农业经济变化在此交汇融合，重新定义了生产者和服务提供者如何优先考虑动物福利、生产力和生物安全。在此背景下，价值链上的所有相关人员必须协调改进疾病预防和诊断技术的需求与劳动力供应、供应链韧性以及对抗菌药物管理日益重视等实际限制因素。本导言透过识别影响产品需求、分销选择和农场层级决策转变的因素，为后续分析提供了一个框架。

诊断创新、抗菌药物管理、不断变化的配送模式和精准管理如何重塑产品选择、临床路径和农场韧性

在科学进步、监管调整和相关人员期望变化的推动下，牛健康管理领域正经历着多重变革。诊断技术的快速发展，包括实验室检测和携带式快速检测套组，使得细菌性、病毒性和寄生虫性疾病的早期检测成为可能，从而支持更有针对性的治疗和预防干预措施。同时，对抗菌药物管理的持续重视加速了替代治疗方法和预防措施的推广应用，并推动了饲料添加剂配方的发展，这些配方提供酵素、益生元、益生菌、维生素和矿物质，以增强牛的免疫力和代谢稳定性。

近期关税措施对牛健康价值链采购、供应连续性和筹资策略的营运和策略影响

美国近期采取的关税措施为依赖进口的牛保健供应链环节带来了新的挑战，导致成本结构和筹资策略发生变化。依赖跨境采购活性成分、诊断剂、特殊疫苗成分和某些饲料添加剂的製造商和经销商被迫重新评估供应商关係，实现采购来源多元化，并在某些情况下加快本地化生产，以维持供应的连续性和利润的稳定。这些因应措施促使企业重新关注供应链规划、供应商选择和库存策略，以降低关税带来的衝击。

明确按产品、通路、牛类类别、疾病、给药途径和应用方式进行细分如何指导采购行为和创新重点。

细分市场分析揭示了影响购买行为和产品开发重点的细微需求驱动因素，这些因素涵盖产品类型、分销管道、牛类类别、疾病分类、给药途径和应用领域。在产品类型中，诊断领域呈现两极分化的格局：实验室检测用于支援确诊和监测项目，而快速检测套组则用于支援农场和诊所的现场决策。消毒剂和杀菌剂在需要严格生物安全措施的地区受到优先考虑，而饲料添加剂则包括酵素、益生元、益生菌以及用于全面改善消化效率和免疫能力的维生素和矿物质。

了解影响产品引进和供应链设计的区域性法规结构、生产系统和分销动态差异

区域趋势对牛健康管理的法规结构、疾病流行情况、生产系统和商业策略有显着影响。在美洲，一体化的商业性运营、先进的兽医基础设施以及不断变化的消费者期望，推动了对高效疫苗、精准诊断以及配套药品和饲料添加剂的需求，促使供应商将可追溯性和性能数据作为差异化优势。在欧洲、中东和非洲地区，不同的监管规定和生产规模导致了产品应用模式的差异。有些市场优先考虑高科技诊断和严格的抗​​生素监管，而有些市场则需要对成本敏感的配方和完善的低温运输物流来应对地方性疾病的压力。

竞争洞察：整合产品供应、证据产生和经销伙伴如何定义牛健康市场的领导地位

牛健康领域的竞争动态呈现出多元化的态势，既有跨国製药公司，也有专业动物保健公司、诊断创新企业和新兴饲料添加剂专家。主要企业透过整合疫苗、标靶药物、诊断技术和技术服务，提供端到端的牛健康解决方案，脱颖而出，深受具有前瞻性思维的养殖户青睐。同时，规模较小、更灵活的公司则倾向于专注于细分市场，例如快速照护现场诊断、新型益生菌配方或针对地方性病原体的社区疫苗平台。

为製造商和经销商提供切实可行、影响深远的策略性倡议，以增强韧性、加速产品推广并改善县级健康结果。

行业领导者应优先采取一系列行动，以把握不断变化的市场需求，同时降低营运风险。首先，投资诊断能力建设，以支持农场快速决策，并将诊断结果转化为可操作的治疗和预防通讯协定。其次，加速采购和生产多元化，以降低贸易中断带来的风险，同时加强供应商选择标准和库存策略，以确保供应的连续性。

采用透明的混合方法研究途径，结合相关人员访谈、监管审查和比较分析，以支持可操作的牛健康见解。

本分析整合了来自行业相关人员访谈的定性和定量资讯、二手文献综述以及对监管和贸易趋势的比较评估，从而对牛健康趋势提供了全面而平衡的观点。主要研究包括与兽医、产品经理、分销主管和农场经理进行结构化对话，以收集有关诊断使用模式、治疗偏好和采购行为的实地见解。这些直接观察结果与公开的监管文件、疾病管理和药理学方面的科学文献以及检验的公司资讯披露进行了三角验证，以确保其准确性。

将策略性问题与诊断技术、合理应用和供应链韧性相结合：从而实现牛健康管理的永续改进

总之，牛健康产业正经历积极的变革时期期，诊断技术的进步、管理的重要性以及分销管道的创新正在重塑商业性和临床规范。那些能够整合产品开发、供应链韧性以及与兽医和生产者开展循证合作的企业，将更有利于影响技术应用并改善动物福利。由于区域差异和关税等因素，供应方面的考量凸显了製定客製化策略和灵活采购的重要性，以维持业务的连续性和竞争力。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 扩大精准畜牧监测技术在疾病早期检测的应用
  • 牛饲料中对植物性抗生素和益生菌等抗生素替代品的需求不断增长
  • 扩大数据驱动决策支援平台在畜群健康管理的应用
  • 增加远距远端照护解决方案的投资，用于远距兽医诊断和治疗
  • 更重视以福利为中心的牛运输通讯协定，以最大程度地减少与压力相关的健康问题
  • 运用区块链技术提升整个供应链中疾病控制的可追溯性
  • 监管改革旨在鼓励减少抗菌药物使用并促进负责任的抗菌药物管理。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的牛健康管理市场

  • 诊断
    • 实验室检测
    • 快速检测套组
  • 消毒剂和清洁剂
  • 饲料添加剂
    • 酵素
    • 益生元和益生菌
    • 维生素和矿物质
  • 製药
    • 驱虫药
    • 抗发炎药
    • 抗生素
    • 激素和生长促进剂
  • 疫苗
    • 细菌
    • 寄生虫
    • 病毒性的

第九章牛健康管理市场（依通路划分）

  • 农资供应商店
  • 线上管道
  • 药局
  • 兽医医院和诊所

第十章 按牛隻类型分類的牛保健市场

  • 牛
  • 牛
  • 牛

第十一章 依疾病类型分類的牛健康管理市场

  • 细菌性疾病
  • 代谢性疾病
  • 寄生虫病
  • 生殖疾病
  • 呼吸系统疾病
  • 病毒性疾病

第十二章 按给药途径分類的牛保健市场

  • 吸入
  • 注射
  • 口服
  • 外用

第十三章牛健康管理市场：依应用领域划分

  • 促进生长
  • 营养补充
  • 预防
  • 繁殖管理
  • 治疗

第十四章牛健康管理市场：依地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章牛健康管理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国牛健康管理市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • Ceva Sante Animale SA
    • Virbac SA
    • Dechra Pharmaceuticals PLC
    • Vetoquinol SA
    • Phibro Animal Health Corporation
    • Neogen Corporation
Product Code: MRR-1A1A064C0406

The Cattle Health Market is projected to grow by USD 12.32 billion at a CAGR of 5.76% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.87 billion
Estimated Year [2025] USD 8.33 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 5.76%

A concise contextual overview of the forces redefining cattle health priorities, clinical practice, and farm-level decision-making in modern animal management

The cattle health landscape is at a crossroads where scientific progress, regulatory evolution, and shifting farm economics are converging to redefine how producers and service providers prioritize animal welfare, productivity, and biosecurity. In this context, stakeholders across the value chain must reconcile the push for improved disease prevention and diagnostics with practical constraints such as labor availability, supply chain resilience, and rising emphasis on antimicrobial stewardship. This introduction frames the subsequent analysis by clarifying the forces shaping product demand, influencing distribution choices, and altering farm-level decision-making.

This report centers on the tangible intersections between innovation and implementation: how laboratory and point-of-care diagnostics are altering clinical workflows; how feed additives and targeted pharmaceuticals are being integrated into herd health plans; and how vaccines, both established and emerging, are being deployed to mitigate infectious and parasitic challenges. By establishing this baseline, readers will gain a clear understanding of why certain intervention categories are gaining prominence and how institutional and farm-level priorities are adapting in response to animal health imperatives and market pressures.

Throughout the ensuing sections, we connect strategic implications to operational realities, helping executives, product managers, and veterinarians align R&D, commercial planning, and on-the-ground practices to improve cattle health outcomes while managing cost and compliance considerations.

How diagnostic innovation, antimicrobial stewardship, distribution evolution, and precision management are reshaping product selection, clinical pathways, and farm resilience

The landscape of cattle health is experiencing several transformative shifts driven by scientific advances, regulatory recalibration, and changing stakeholder expectations. Rapid improvements in diagnostics technology, including laboratory testing and portable rapid test kits, are enabling earlier detection of bacterial, viral, and parasitic conditions, which in turn supports more targeted therapeutic and preventive interventions. Simultaneously, continued emphasis on antimicrobial stewardship is accelerating adoption of alternative therapeutics and preventive measures, incentivizing growth in feed additive formulations that deliver enzymes, prebiotics, probiotics, vitamins, and minerals to support immunity and metabolic stability.

Distribution models are evolving as well, with online channels complementing traditional farm supply outlets, pharmacies, and veterinary hospitals to improve accessibility and traceability of products. Regulatory scrutiny around hormones and growth promoters, coupled with heightened consumer interest in sustainable and welfare-oriented production, is prompting manufacturers to diversify portfolios toward vaccines and non-antibiotic therapeutic options. In parallel, data-driven herd management and precision livestock farming techniques are informing product selection and administration routes, with injectable, oral, topical, and inhalation options being deployed in more strategic and condition-specific ways.

Taken together, these shifts signal a move from broad, reactive interventions toward integrated, preventive, and data-informed strategies that prioritize herd resilience, product safety, and long-term viability for producers and value chain partners.

Operational and strategic consequences of recent tariff measures on sourcing, supply continuity, and procurement strategies across the cattle health value chain

Recent tariff actions in the United States introduced new considerations for import-dependent segments of the cattle health supply chain, altering cost structures and procurement strategies. Manufacturers and distributors that rely on cross-border sourcing for active pharmaceutical ingredients, diagnostic reagents, specialized vaccine components, and certain feed additive raw materials have had to reassess supplier relationships, diversify sourcing footprints, and, in some instances, accelerate localization of production to maintain supply continuity and margin stability. These operational responses have translated into renewed emphasis on supply chain mapping, vendor qualification, and inventory strategies to reduce exposure to tariff-driven disruptions.

At the same time, regulatory agencies and trade partners are adapting to the changed trade environment through procedural clarifications and bilateral dialogues intended to minimize unintended consequences for animal health inputs. The net effect for industry participants is a heightened need for commercial agility: procurement teams are pursuing multi-sourcing and strategic stockholding while product managers are evaluating reformulation opportunities that reduce reliance on tariff-sensitive inputs. Veterinary service providers and farm operators are also adjusting purchasing cadence and product selection, preferring accessible distribution channels that mitigate delivery risks.

In short, tariffs have reinforced the strategic importance of resilient value chains, compelling companies across the cattle health ecosystem to invest in sourcing flexibility, supplier partnerships, and near-term operational contingency planning to safeguard animal care and business continuity.

Clarifying how product, channel, cattle category, disease, administration route, and application segmentation combine to direct purchasing behavior and innovation priorities

Segmentation analysis reveals nuanced demand drivers across product types, distribution channels, cattle categories, disease classes, administration routes, and applications, each shaping purchasing behavior and product development priorities. Within product categories, diagnostics present a bifurcated landscape where laboratory testing supports confirmatory and surveillance programs while rapid test kits enable point-of-care decision-making on farms and in clinics. Disinfectants and sanitizers are prioritized where biosecurity protocols are stringent, and feed additives span enzymes, prebiotics and probiotics, plus vitamins and minerals that collectively address digestive efficiency and immune competence.

Pharmaceutical portfolios require careful segmentation: anthelmintics remain essential for parasite control, anti-inflammatories address acute clinical needs, antibiotics are increasingly subject to stewardship constraints, and hormones and growth promoters face regulatory and market scrutiny that influence adoption. Vaccines span bacterial, parasitic, and viral targets and are central to preventive herd health strategies. Distribution patterns show that farm supplies outlets continue to be primary procurement points for routine products, while online channels are expanding accessibility and transactional efficiency; pharmacies and veterinary hospitals and clinics play critical roles for prescription and professionally administered interventions.

Cattle types-beef, calves, and dairy-exhibit distinct health management priorities linked to production cycles, nutrition, and disease susceptibility, driving divergent demand for formulation types and administration routes. Disease-type segmentation underscores the breadth of clinical focus areas, from bacterial and viral infections to parasitic and metabolic disorders and reproductive and respiratory conditions, each requiring tailored diagnostic, preventive, and therapeutic approaches. Administration routes-injectable, oral, topical, and inhalation-must align with product pharmacokinetics, ease of use on farm, and welfare considerations. Finally, applications ranging from growth promotion and nutritional supplementation to preventive, reproductive management, and therapeutic uses determine how products are positioned commercially and integrated into herd health programs.

Understanding regional variation in regulatory frameworks, production systems, and distribution dynamics that shape product adoption and supply chain design

Regional dynamics exert a strong influence on regulatory frameworks, disease prevalence, production systems, and commercial strategies in cattle health. In the Americas, integrated commercial operations, advanced veterinary infrastructure, and evolving consumer expectations drive demand for high-efficacy vaccines, precision diagnostics, and stewardship-aligned pharmaceuticals and feed additives, prompting suppliers to emphasize traceability and performance data as differentiators. Across Europe, the Middle East and Africa, regulatory diversity and varied production scales mean that product adoption patterns diverge: some markets prioritize high-tech diagnostics and stringent antibiotic regulations, while others require cost-sensitive formulations and robust cold-chain logistics to manage endemic disease pressures.

Asia-Pacific presents distinct dynamics with rapid modernization of dairy and beef systems, heterogeneous disease burdens, and expanding distribution ecosystems where online channels and veterinary clinics are increasingly influential. Regional procurement and supply chain approaches reflect these conditions: manufacturers adapt packaging, formulations, and support services for diverse cold-chain capabilities, veterinary capacity, and farm management practices. Moreover, public and private sector disease control programs and regional trade policies shape vaccine deployment strategies and prioritize interventions that address prevalent bacterial, viral, and parasitic challenges.

Understanding these regional nuances enables companies to align product development, registration strategies, and commercial engagement to the specific needs of producers, veterinarians, and regulators in each geography, thereby improving adoption and impact.

Competitive landscape insights highlighting how integrated product offerings, evidence generation, and distribution partnerships define leadership in cattle health markets

Competitive dynamics in the cattle health space reflect a mix of multinational pharmaceutical firms, specialized animal health companies, diagnostic innovators, and emerging feed additive specialists. Leading players differentiate through integrated offerings that combine vaccines, targeted pharmaceuticals, diagnostics, and technical services, enabling end-to-end herd health solutions that resonate with progressive producers. Meanwhile, smaller, agile firms often focus on niche opportunities such as rapid point-of-care diagnostics, novel probiotic blends, or localized vaccine platforms that address region-specific pathogens.

Collaboration between manufacturers and veterinary services is a growing strategic priority, with companies investing in field trials, real-world evidence generation, and educational programs to demonstrate product value and encourage protocol adoption. Strategic partnerships with distribution networks, including online platforms and veterinary hospitals, are expanding reach and streamlining procurement, while investments in cold-chain logistics and regulatory affairs capabilities help accelerate market entry and maintain product integrity. Additionally, companies are increasingly transparent about stewardship commitments and data transparency, which strengthens trust with veterinarians, producers, and regulators.

Going forward, competitive advantage will accrue to organizations that combine technical innovation with robust supply chain safeguards, evidence-based engagement, and services that lower adoption friction for farm operators and clinical practitioners.

Practical, high-impact strategic moves for manufacturers and distributors to strengthen resilience, accelerate adoption, and improve herd-level health outcomes

Industry leaders should pursue a set of prioritized actions to capitalize on evolving demand while reducing operational risk. First, invest in diagnostic capabilities that support rapid, on-farm decision-making and link diagnostic outputs to actionable treatment and prevention protocols. Second, accelerate diversification of sourcing and production to reduce exposure to trade-related disruptions, while strengthening supplier qualification and inventory strategies to maintain continuity of supply.

Third, reframe product portfolios to emphasize antimicrobial stewardship and non-antibiotic interventions, pairing therapeutics with vaccination strategies and targeted feed additives that support immune resilience and metabolic health. Fourth, deepen engagement with distribution partners across farm supply outlets, online channels, pharmacies, and veterinary hospitals to enhance accessibility and ensure appropriate product use. Fifth, tailor regional go-to-market approaches that reflect the distinct regulatory, logistical, and disease prevalence conditions in the Americas, Europe Middle East & Africa, and Asia-Pacific, and invest in localized trials and educational outreach to support adoption.

Finally, augment competitive positioning by generating robust field data, leveraging digital tools for herd-level insights, and offering service-oriented solutions that simplify adoption. Taken together, these steps will enable companies to deliver higher value, mitigate operational risk, and align product strategy with the practical needs of veterinarians and producers.

Transparent mixed-methods research approach combining stakeholder interviews, regulatory review, and comparative analysis to support actionable cattle health insights

This analysis synthesizes qualitative and quantitative inputs drawn from primary interviews with industry stakeholders, secondary literature review, and comparative assessment of regulatory and trade developments to ensure a comprehensive and balanced perspective on cattle health dynamics. Primary research included structured conversations with veterinary practitioners, product managers, distribution executives, and farm operators to capture on-the-ground insights into diagnostic use patterns, treatment preferences, and procurement behaviors. These firsthand observations were triangulated with public regulatory documentation, scientific literature on disease management and pharmacology, and validated company disclosures to enhance accuracy.

The methodology emphasizes transparency and replicability: sources were documented, thematic coding was applied to interview data, and cross-validation checks were conducted to reconcile divergent viewpoints. Where appropriate, scenario analysis was used to assess operational responses to trade and supply chain disruptions, while technology and adoption trends were evaluated through product pipeline reviews and stakeholder readiness assessments. This mixed-methods approach ensures the findings reflect both technical realities and commercial practicalities relevant to decision-makers across the cattle health ecosystem.

Synthesis of strategic imperatives emphasizing diagnostics, stewardship, and supply chain resilience to guide sustainable improvements in cattle health management

In conclusion, the cattle health sector is navigating a period of constructive disruption where diagnostic advances, stewardship imperatives, and distribution innovations are reshaping commercial and clinical norms. Companies that align product development, supply chain resilience, and evidence-based engagement with veterinarians and producers will be better positioned to influence adoption and improve animal welfare outcomes. Regional heterogeneity and tariff-induced supply considerations underscore the importance of tailored strategies and sourcing flexibility to maintain continuity and competitiveness.

The practical implications for stakeholders are clear: prioritize diagnostics and preventive measures that reduce reliance on broad-spectrum therapeutics, invest in formulation and logistics that suit local production systems, and cultivate partnerships that bring clinical credibility and distribution efficiency. By translating these insights into coordinated action-spanning R&D prioritization, supplier diversification, and targeted market engagement-industry participants can address immediate operational challenges while building sustainable pathways for long-term improvement in cattle health.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of precision livestock monitoring technologies for early disease detection
  • 5.2. Rising demand for antibiotic alternatives such as phytogenics and probiotics in cattle feed
  • 5.3. Introduction of next generation mRNA vaccines targeting bovine respiratory diseases
  • 5.4. Increasing utilization of data-driven decision support platforms for herd health management
  • 5.5. Expanding investments in telemedicine solutions for remote veterinary diagnostics and treatment
  • 5.6. Enhanced focus on welfare-driven cattle transport protocols to minimize stress-induced health issues
  • 5.7. Integration of blockchain technology for traceable disease control across supply chains
  • 5.8. Regulatory shifts incentivizing reduced antimicrobial usage and promoting responsible stewardship

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cattle Health Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Laboratory Testing
    • 8.1.2. Rapid Test Kits
  • 8.2. Disinfectants & Sanitizers
  • 8.3. Feed Additives
    • 8.3.1. Enzymes
    • 8.3.2. Prebiotics & Probiotics
    • 8.3.3. Vitamins & Minerals
  • 8.4. Pharmaceuticals
    • 8.4.1. Anthelmintics
    • 8.4.2. Anti-Inflammatories
    • 8.4.3. Antibiotics
    • 8.4.4. Hormones & Growth Promoters
  • 8.5. Vaccines
    • 8.5.1. Bacterial
    • 8.5.2. Parasitic
    • 8.5.3. Viral

9. Cattle Health Market, by Distribution Channel

  • 9.1. Farm Supplies Outlets
  • 9.2. Online Channels
  • 9.3. Pharmacies
  • 9.4. Veterinary Hospitals & Clinics

10. Cattle Health Market, by Cattle Type

  • 10.1. Beef
  • 10.2. Calves
  • 10.3. Dairy

11. Cattle Health Market, by Disease Type

  • 11.1. Bacterial Diseases
  • 11.2. Metabolic Disorders
  • 11.3. Parasitic Diseases
  • 11.4. Reproductive Disorders
  • 11.5. Respiratory Disorders
  • 11.6. Viral Diseases

12. Cattle Health Market, by Route Of Administration

  • 12.1. Inhalation
  • 12.2. Injectable
  • 12.3. Oral
  • 12.4. Topical

13. Cattle Health Market, by Application

  • 13.1. Growth Promotion
  • 13.2. Nutritional Supplementation
  • 13.3. Preventive
  • 13.4. Reproductive Management
  • 13.5. Therapeutic

14. Cattle Health Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cattle Health Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cattle Health Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Zoetis Inc.
    • 17.3.2. Merck & Co., Inc.
    • 17.3.3. Boehringer Ingelheim International GmbH
    • 17.3.4. Elanco Animal Health Incorporated
    • 17.3.5. Ceva Sante Animale SA
    • 17.3.6. Virbac SA
    • 17.3.7. Dechra Pharmaceuticals PLC
    • 17.3.8. Vetoquinol SA
    • 17.3.9. Phibro Animal Health Corporation
    • 17.3.10. Neogen Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CATTLE HEALTH MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CATTLE HEALTH MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CATTLE HEALTH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CATTLE HEALTH MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE HEALTH MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CATTLE HEALTH MARKET SIZE, BY LABORATORY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE HEALTH MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISINFECTANTS & SANITIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE HEALTH MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREBIOTICS & PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CATTLE HEALTH MARKET SIZE, BY VITAMINS & MINERALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTHELMINTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTI-INFLAMMATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CATTLE HEALTH MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CATTLE HEALTH MARKET SIZE, BY HORMONES & GROWTH PROMOTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CATTLE HEALTH MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CATTLE HEALTH MARKET SIZE, BY FARM SUPPLIES OUTLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CATTLE HEALTH MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CATTLE HEALTH MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CATTLE HEALTH MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CATTLE HEALTH MARKET SIZE, BY BEEF, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CATTLE HEALTH MARKET SIZE, BY CALVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CATTLE HEALTH MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CATTLE HEALTH MARKET SIZE, BY BACTERIAL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CATTLE HEALTH MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CATTLE HEALTH MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CATTLE HEALTH MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CATTLE HEALTH MARKET SIZE, BY VIRAL DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CATTLE HEALTH MARKET SIZE, BY INHALATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CATTLE HEALTH MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CATTLE HEALTH MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CATTLE HEALTH MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CATTLE HEALTH MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CATTLE HEALTH MARKET SIZE, BY NUTRITIONAL SUPPLEMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CATTLE HEALTH MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CATTLE HEALTH MARKET SIZE, BY REPRODUCTIVE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CATTLE HEALTH MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CATTLE HEALTH MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY CATTLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY DISEASE TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA CATTLE HEALTH MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY FEED ADDITIVES, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPE, MIDDLE EAST & AFRICA CATTLE HEALTH MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)

TABL